Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.

Johnson MW, MacLean KA, Reissig CJ, Prisinzano TE, Griffiths RR.

Drug Alcohol Depend. 2011 May 1;115(1-2):150-5. doi: 10.1016/j.drugalcdep.2010.11.005. Epub 2010 Dec 4.

PMID:
21131142
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects.

MacLean KA, Johnson MW, Reissig CJ, Prisinzano TE, Griffiths RR.

Psychopharmacology (Berl). 2013 Mar;226(2):381-92. doi: 10.1007/s00213-012-2912-9. Epub 2012 Nov 8.

PMID:
23135605
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Acute and post-acute behavioral and psychological effects of salvinorin A in humans.

Addy PH.

Psychopharmacology (Berl). 2012 Mar;220(1):195-204. doi: 10.1007/s00213-011-2470-6. Epub 2011 Sep 8.

PMID:
21901316
[PubMed - indexed for MEDLINE]
4.

Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug.

Zawilska JB, Wojcieszak J.

Hum Psychopharmacol. 2013 Sep;28(5):403-12. doi: 10.1002/hup.2304. Epub 2013 Jun 23. Review.

PMID:
23794315
[PubMed - indexed for MEDLINE]
5.

The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.

Butelman ER, Harris TJ, Kreek MJ.

Psychopharmacology (Berl). 2004 Mar;172(2):220-4. Epub 2003 Oct 30.

PMID:
14586540
[PubMed - indexed for MEDLINE]
6.

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB.

Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11934-9. Epub 2002 Aug 21.

PMID:
12192085
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.

Willmore-Fordham CB, Krall DM, McCurdy CR, Kinder DH.

Neuropharmacology. 2007 Sep;53(4):481-6. Epub 2007 Jun 27.

PMID:
17681558
[PubMed - indexed for MEDLINE]
8.

Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Cunningham CW, Rothman RB, Prisinzano TE.

Pharmacol Rev. 2011 Jun;63(2):316-47. doi: 10.1124/pr.110.003244. Epub 2011 Mar 28. Review.

PMID:
21444610
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.

Ranganathan M, Schnakenberg A, Skosnik PD, Cohen BM, Pittman B, Sewell RA, D'Souza DC.

Biol Psychiatry. 2012 Nov 15;72(10):871-9. doi: 10.1016/j.biopsych.2012.06.012. Epub 2012 Jul 18.

PMID:
22817868
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid.

Butelman ER, Prisinzano TE, Deng H, Rus S, Kreek MJ.

J Pharmacol Exp Ther. 2009 Feb;328(2):588-97. doi: 10.1124/jpet.108.145342. Epub 2008 Nov 10.

PMID:
19001155
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors.

Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ.

Psychopharmacology (Berl). 2005 May;179(3):551-8. Epub 2005 Jan 29.

PMID:
15682306
[PubMed - indexed for MEDLINE]
12.

Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.

Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, Toth BA, Hufeisen SJ, Roth BL.

J Pharmacol Exp Ther. 2004 Mar;308(3):1197-203. Epub 2004 Jan 8.

PMID:
14718611
[PubMed - indexed for MEDLINE]
Free Article
13.

Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo.

Butelman ER, Caspers M, Lovell KM, Kreek MJ, Prisinzano TE.

J Pharmacol Exp Ther. 2012 Jun;341(3):802-8. doi: 10.1124/jpet.112.193227. Epub 2012 Mar 20.

PMID:
22434677
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.

Butelman ER, Rus S, Prisinzano TE, Kreek MJ.

Psychopharmacology (Berl). 2010 Jun;210(2):253-62. doi: 10.1007/s00213-009-1771-5. Epub 2010 Jan 19.

PMID:
20084367
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial.

Mendelson JE, Coyle JR, Lopez JC, Baggott MJ, Flower K, Everhart ET, Munro TA, Galloway GP, Cohen BM.

Psychopharmacology (Berl). 2011 Apr;214(4):933-9. doi: 10.1007/s00213-010-2103-5. Epub 2010 Dec 8.

PMID:
21140258
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Salvia divinorum use and phenomenology: results from an online survey.

Sumnall HR, Measham F, Brandt SD, Cole JC.

J Psychopharmacol. 2011 Nov;25(11):1496-507. doi: 10.1177/0269881110385596. Epub 2010 Oct 11.

PMID:
20937616
[PubMed - indexed for MEDLINE]
17.

Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans.

Butelman ER, Mandau M, Tidgewell K, Prisinzano TE, Yuferov V, Kreek MJ.

J Pharmacol Exp Ther. 2007 Jan;320(1):300-6. Epub 2006 Oct 23.

PMID:
17060493
[PubMed - indexed for MEDLINE]
Free Article
18.

Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.

Ansonoff MA, Zhang J, Czyzyk T, Rothman RB, Stewart J, Xu H, Zjwiony J, Siebert DJ, Yang F, Roth BL, Pintar JE.

J Pharmacol Exp Ther. 2006 Aug;318(2):641-8. Epub 2006 May 3.

PMID:
16672569
[PubMed - indexed for MEDLINE]
Free Article
19.

Psychopharmacology of the hallucinogenic sage Salvia divinorum.

Prisinzano TE.

Life Sci. 2005 Dec 22;78(5):527-31. Epub 2005 Oct 6. Review.

PMID:
16213533
[PubMed - indexed for MEDLINE]
20.

Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.

Fantegrossi WE, Kugle KM, Valdes LJ 3rd, Koreeda M, Woods JH.

Behav Pharmacol. 2005 Dec;16(8):627-33.

PMID:
16286814
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk